Jean-Pierre Frat Selected Research

Respiratory Insufficiency (Respiratory Failure)

1/2022	Noninvasive Oxygenation in Patients with Acute Respiratory Failure: Current Perspectives.
1/2022	ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure.
1/2022	High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial.
12/2021	Comparison of high-flow nasal oxygen therapy and non-invasive ventilation in ICU patients with acute respiratory failure and a do-not-intubate orders: a multicentre prospective study OXYPAL.
8/2021	Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS.
7/2021	Noninvasive ventilation vs. high-flow nasal cannula oxygen for preoxygenation before intubation in patients with obesity: a post hoc analysis of a randomized controlled trial.
1/2021	What is the most adequate non-invasive oxygen support for acute hypoxaemic respiratory failure due to COVID-19?
1/2021	Non-invasive ventilation versus high-flow nasal oxygen for postextubation respiratory failure in ICU: a post-hoc analysis of a randomized clinical trial.
1/2021	Noninvasive ventilation and high-flow nasal oxygen for acute respiratory failure: is less more?
1/2021	Survival in Immunocompromised Patients Ultimately Requiring Invasive Mechanical Ventilation: A Pooled Individual Patient Data Analysis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Pierre Frat Research Topics

Disease

43	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 08/2014
6	Critical Illness (Critically Ill) 01/2022 - 08/2010
5	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 08/2021 - 09/2016
5	Hypoxia (Hypoxemia) 07/2021 - 06/2015
4	Lung Diseases (Lung Disease) 01/2022 - 03/2015
4	Heart Arrest (Cardiac Arrest) 01/2022 - 01/2019
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2019
3	Respiratory Acidosis 01/2022 - 01/2019
3	Obesity 01/2022 - 12/2020
3	Hypercapnia 01/2022 - 06/2015
3	Coma (Comas) 01/2022 - 01/2019
3	Body Weight (Weight, Body) 12/2020 - 11/2014
2	Sepsis (Septicemia) 12/2021 - 11/2014
2	Infections 12/2021 - 01/2013
2	COVID-19 04/2021 - 01/2021
2	Dyspnea (Shortness of Breath) 01/2020 - 11/2019
2	Ventilator-Associated Pneumonia 01/2019 - 01/2013
2	Pneumonia (Pneumonitis) 01/2018 - 02/2006
2	Pulmonary Aspergillosis 01/2016 - 03/2015
1	Overweight 01/2022
1	Allergic Bronchopulmonary Aspergillosis 01/2022
1	Shock 01/2022
1	Reperfusion Injury 01/2022
1	Mental Disorders (Mental Disorder) 05/2021
1	Pulmonary Embolism 04/2021
1	Brain Injuries (Brain Injury) 01/2021
1	Out-of-Hospital Cardiac Arrest 12/2019
1	Hypothermia 12/2019
1	Barotrauma 12/2019
1	Hypotension (Low Blood Pressure) 01/2019
1	Cystic Fibrosis (Mucoviscidosis) 12/2018
1	Apnea 12/2017
1	Clinical Deterioration 01/2016
1	Tachypnea 02/2015
1	Septic Shock (Toxic Shock Syndrome) 11/2014
1	Vomiting 01/2013
1	Pressure Ulcer (Bedsore) 11/2008
1	Cross Infection (Nosocomial Infection) 11/2008
1	Bezoars (Bezoar) 01/2005
1	Poisoning 01/2005
1	Asthma (Bronchial Asthma) 06/2004
1	Crohn Disease (Crohn's Disease) 05/2004

Drug/Important Bio-Agent (IBA)

38	Oxygen (Dioxygen)IBA 01/2022 - 02/2015
2	liposomal amphotericin B FDA Link 01/2022 - 03/2015
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2021
2	Albuterol (Salbutamol)FDA LinkGeneric 10/2021 - 01/2019
1	Biological ProductsIBA 12/2021
1	Bronchodilator Agents (Bronchodilators)IBA 10/2021
1	Antipsychotic Agents (Antipsychotics)IBA 05/2021
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 04/2021
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 12/2019
1	GasesIBA 11/2019
1	ChlorhexidineIBA 01/2018
1	TriazolesIBA 03/2015
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2014
1	Colistin (Coly-Mycin)FDA Link 08/2010
1	Amitriptyline (Elavil)FDA LinkGeneric 01/2005
1	Digoxin (Digitek)FDA LinkGeneric 01/2005
1	Terbutaline (Brethaire)FDA LinkGeneric 06/2004
1	Epinephrine (Adrenaline)FDA LinkGeneric 06/2004
1	Dipyrone (Metamizole)IBA 05/2004
1	Methotrexate (Mexate)FDA LinkGeneric 05/2004

Therapy/Procedure

33	Noninvasive Ventilation 01/2022 - 08/2014
32	Therapeutics 01/2022 - 08/2014
19	Cannula 01/2022 - 02/2015
5	Artificial Respiration (Mechanical Ventilation) 01/2021 - 01/2013
5	Length of Stay 11/2020 - 01/2013
4	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2022 - 06/2015
3	Contraindications 01/2022 - 01/2019
3	Resuscitation 01/2021 - 11/2014
2	Induced Hypothermia 01/2022 - 12/2019
2	Catheters 11/2008 - 02/2006
1	Continuous Positive Airway Pressure 01/2022
1	Airway Management 12/2020
1	Aftercare (After-Treatment) 11/2019
1	Drug Therapy (Chemotherapy) 03/2015
1	Enteral Nutrition (Feeding, Tube) 01/2013